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Abstract
Background: Otologic manifestations are one of the most consistent findings of CHARGE syndrome found in more than
90%. Since genetic analysis of the CHD7 gene has rarely been performed in previous reports dealing with ear abnormalities,
the genotypic spectrum of CHD7 mutations was analyzed in deaf patients with CHARGE syndrome, and the clinical
considerations concerning auditory rehabilitation were investigated.
Methods: Nine Korean patients with CHARGE syndrome showing profound hearing loss and semicircular canal aplasia were
included. All 38 exons of CHD7 were analyzed by direct sequencing. For splice site variations, in silico and exon-trapping
analyses were performed to verify the pathogenicity of nucleotide variations. Clinical features and the outcome of auditory
rehabilitation were also analyzed.
Results: Eight of 9 patients revealed alterations of the CHD7 gene including 3 frameshift, 2 nonsense, 2 splice site, and 1
missense mutations. Five of 9 patients were clinically diagnosed as atypical CHARGE syndrome but demonstrated various
mutations of the CHD7 gene. One familial case showed intra-familial variability. Radiologic findings suggesting
cochleovestibular nerve deficiency were identified in most of the patients. Of the 8 patients who underwent cochlear
implantation, 5 patients demonstrated favorable outcome. Larger diameter of the cochleovestibular nerve on imaging and
absence of severe mental retardation were factors related to better outcome after cochlear implantation rather than the
type of CHD7 mutations. Auditory brainstem implantation was performed in two patients who did not benefit from cochlear
implantation.
Conclusions: Genetic analysis of the CHD7 gene should be performed in cases with semicircular canal aplasia even when
other typical features of CHARGE syndrome are absent. For auditory rehabilitation in CHARGE syndrome, cochlear
implantation should be strongly recommended in selected cases with favorable prognostic factors. Auditory brainstem
implantation may be a viable option in patients with CHARGE syndrome who have failed to benefit from cochlear
implantation.
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Introduction
CHARGE is an acronym describing a set of conditions
including ‘‘C’’oloboma of eye, ‘‘H’’eart malformations, ‘‘A’’tresia
of choanae, ‘‘R’’etardation in growth and development, ‘‘G’’enital
hypoplasia, and ‘‘E’’ar anomalies. The combination of these
anomalies was first reported by Hall and Hittner [1,2] in 1979
after which the acronym was proposed by Pagon et al. [3] in 1981.
The diagnostic criteria proposed by Blake et al. [4] in 1998 and
those updated by Verloes [5] emphasizing the importance of
semicircular canal hypoplasia or aplasia are widely used today for
the clinical diagnosis of CHARGE syndrome. The incidence of
CHARGE syndrome is approximately 1/10,000 and most of the
cases are sporadic although 17 familial cases have been reported to
date [6]. The mode of inheritance is autosomal dominance with
variable penetrance [6].
Haploinsufficiency of the CHD7 gene has been identified as the
molecular basis of CHARGE syndrome by Vissers et al. [7] in
2004. The CHD7 gene located on chromosome 8q12.1 is 188 kb in
size and consists of 37 coding and one non-coding exons [7]. The
CHD7 protein comprised of 2,997 amino acids belongs to the
chromodomain helicase DNA binding family, one of the four
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Approximately 60–70% of patients clinically diagnosed as
CHARGE syndrome were found to have pathogenic mutations
in the CHD7 gene [8]. Truncating mutations including nonsense
or frameshift mutations are the most frequently encountered forms
of genetic alterations followed by splice site or missense mutations
found in lower incidences [8]. Chromosomal abnormalities with or
without involvement of the CHD7 gene also have been reported to
cause phenotypic features of CHARGE syndrome [9].
Among the various clinical manifestations of CHARGE
syndrome, otologic symptoms and signs are one of the most
consistent findings which are included as one of the major criteria
in both Blake’s and Verloes’ clinical criteria [4,5]. Characteristic
temporal bone anomalies are reported to be found in 98% of
CHD7 mutation positive cases along with external ear malforma-
tions and hearing loss also found in more than 90% [8,9]. Analysis
of temporal bone computed tomography (CT) findings has
revealed aplasia or hypoplasia of the semicircular canal, cochlear
dysplasia, atresia of bony cochlear nerve canal (BCNC), oval
window atresia, ossicular malformations as common characteris-
tics of CHARGE syndrome [10]. Although mild semicircular
canal dysplasia is one of the most commonly seen inner ear
anomalies, complete aplasia of the semicircular canals with
relatively intact cochlear structures is a very rare condition. Since
CHARGE syndrome manifests a variety of different conditions
that may overlap other syndromes such as velocardiofacial
syndrome or Noonan syndrome, aplasia of the semicircular canals
may be a decisive clue in suspecting CHARGE syndrome leading
to molecular analysis of the CHD7gene [11,12].
Considering that hearing loss of variable degrees is present in
most of the cases with CHARGE syndrome, auditory rehabilitation
is another important factor in the management of these patients. It
has been reported that early auditory rehabilitation is especially
important in patients with multiple disabilities for adequate
development of communication skills [13]. In CHARGE syndrome
patients with severe to profound hearing loss, cochlear implantation
(CI) has resulted in variable outcomes because of concomitant
multiple handicaps and anatomical factors such as cochlear nerve
aplasia [14,15]. Most of the patients with CHARGE syndrome
achieve limited auditory benefit and improved attentiveness and
responsiveness following CI but open-set speech perception is
acquired in very rare cases [14,16,17].
Although there have been many reports concerning otologic
manifestations and auditory rehabilitation in CHARGE syndrome,
molecular analysis of the CHD7 gene was not performed in most of
the reports [14,16,17]. Genetic analysis is especially important in
CHARGE syndrome considering that this disorder shares many
features with other syndromes which may lead to incorrect diagnosis
and that some patients with mutations in the CHD7 gene manifest
only mild symptoms as seen in familial cases of CHARGE syndrome
[6]. Therefore, in this study, we have performed CHD7 mutational
analysis in Korean patients with CHARGE syndrome presenting
with profound hearing loss and typical inner ear malformations in
order to broaden the genotypic spectrum of CHARGE syndrome.
The clinical features were also analyzed with emphasis on auditory
rehabilitation including CI and auditory brainstem implantation. In
addition, factors that may influence the outcome of auditory
rehabilitation in these patients were further investigated.
Materials and Methods
Subjects
Among the patients who were enrolled in the auditory
rehabilitation program at Severance Hospital, nine patients with
profound sensorineural hearing loss showing semicircular canal
aplasia on the temporal bone CT were included in this study.
Eight of 9 patients received CI for auditory rehabilitation, and two
children underwent subsequent auditory brainstem implantation
because no sound perception was possible using a CI. There were
6 males and 3 females; and the ages of the patients at the time of
CI ranged from 14 months to 20 years (mean: 6.2 years). One
patient aged 15 years was recommended to receive CI but the
parents have refused surgery. Combined disabilities and other
medical conditions were reviewed and further evaluations
including ophthalmologic examination and echocardiography
were performed. Written informed consent was obtained from
participating individuals, and this study was approved by the
Institutional Review Board of the Yonsei University College of
Medicine.
Genetic analysis
From the peripheral blood of 9 subjects, genomic DNA was
extracted using a FlexiGene DNA extraction kit (Qiagen, Hilden,
Germany). All 38 exons and flanking intronic sequences of CHD7
were amplified by polymerase chain reaction (PCR) and the
quality of the PCR products were examined by electrophoresis on
2% agarose gels. The sequences of the primers and PCR
conditions are provided in Table S1. Each fragment was purified
and subsequently sequenced using ABI PRISM Big Dye
Terminator Cycle Sequencing Kit (V3.1) and an ABI
PRISM3130XL DNA analyzer (Applied Biosystems, Foster City,
CA, USA). ABI Sequencing Analysis (v.5.0) and Lasergene–
SeqMan software were used for the data analysis. For the
identified missense variation, the presence of the variant was
evaluated in 100 unrelated Korean subjects who showed normal
audiograms. For chromosomal analysis, leukocytes from the
peripheral blood were cultured and Giemsa staining of the
chromosomes of cells arrested in metaphase was performed for
karyotyping.
Exon trapping analysis
For the two splice site variations, in silico splice site prediction
was analyzed to identify any possible effects of the variation on the
native splicing process. Three online applications were used
for each variation (FruitFly; www.fruitfly.org/seq_tools/splice.
html, NetGene2; www.cbs.dtu.dk/services/NetGene2 and Hu-
man Splicing Finder; www.umd.be/SSF) and the significance was
indicated by a score.
For in vitro splicing assay, mini-gene system vector was
constructed, and the basement vector pSPL3 was kindly provided
by Dr. Thomas v. O. Hansen. DNA sequences containing one or
two exons adjacent to the splice site variations and the ,300-bp
flanking intronic sequences were amplified from the genomic
DNA of patients having heterozygous variations and inserted into
the pSPL3 vector (Table S2). After vector sequencing to isolate
wild type and mutant constructions, the isolated vectors and a
mock pSPL3 vector were transfected into HeLa cells using
FuGENE HD Transfection Reagent (Roche Diagnostics GmbH,
Mannheim, Germany). The transfected cells were lysed 48 hrs
after the tranfection and total RNA was extracted using the
RNeasy Mini Kit (Qiagen, Hilden, Germany). With 1 mg of RNA,
first strand cDNA was synthesized by reverse transcription using
oligo-(dT)16 primer and High Capacity cDNA Reverse Transcip-
tion Kit (Applied Biosystems, Foster City, CA, USA). Using 1 mlo f
cDNA as template, PCR amplification was performed with pSPL3
vector specific primers SD6 and SA2, and the size of the generated
mock, normal, and mutant type PCR fragments were compared
on 2% of agarose gels. The sequence of PCR products were
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cloning to isolate various fragments.
Diagnostic criteria for CHARGE syndrome
The criteria proposed by Verloes [5] were applied for clinical
diagnosis of CHARGE syndrome (Table 1).The three major signs
included coloboma, choanal atresia, and semicircular canal
hypoplasia and the minor signs included rhombencephalic
dysfunction, hypothalamo-hypophyseal dysfunction, abnormal
middle or external ear, malformation of mediastinal organs, and
mental retardation. CHARGE syndrome was classified into
typical, partial/incomplete, or atypical according to the number
of major or minor signs present.
Radiologic evaluations
The temporal bone CT scan was performed with a 16
multidetector row CT scanner (Somatom Sensation 16; Siemens,
Erlangen, Germany) using a standard temporal bone protocol.
Contiguous 0.7-mm scans of the temporal bone were acquired in
the axial plane and reformatted coronally with 1.0-mm incre-
ments. CT images were performed, digitally stored, and displayed
by using the Picture Archiving Communication System (PACS)
(Centricity; GE Healthcare, Milwaukee, WI).
Magnetic resonance imaging (MRI) was acquired by using a
3.0-T (Achieva; Philips Medical Systems, Best, the Netherlands) or
1.5-T system (Intera; Philips Medical Systems, Best, the Nether-
lands) with a six-channel sensitivity encoding (SENSE) head coil.
The targeted parasagittal scan perpendicular to the long axis of the
internal auditory canal was obtained with T2-weighted three-
dimensional (3-D) turbo spin-echo (TSE) sequence with driven
equilibrium RF reset pulse (DRIVE), following routine MR
sequences with spin-echo T1- and T2-weighted images. The
sequence parameters for the T2-weighted 3-D FSE sequence with
DRIVE were as follows: repetition time (TR)/echo time
(TE)=1500/200 ms, 256 acquisition/256 reconstruction, 15-cm
field of view, 1.5-mm section thickness with a 0.75-mm overlap,
number of acquisitions=2, and the scan time was less than
5 minutes.
Audiologic tests and evaluation of speech performances
Audiologic tests including pure tone audiometry, auditory
brainstem response, otoacoustic emission were performed before
undergoing CI. Overall auditory performances were evaluated by
categories of auditory performance (CAP) [18]. Speech evaluations
were performed preoperatively and 1, 3, 6, 12, 18, 24 months after
either CI or auditory brainstem implantation.
Results
Mutations of the CHD7 gene
CHD7 mutations were identified in 8 of 9 patients showing
characteristics of CHARGE syndrome (Table 2). Six mutations
were found in the coding sequence while two were intronic
variations suspected of splice site mutations. The mutations in the
coding sequence included 3 frameshift mutations causing trunca-
tion of the protein, 2 nonsense mutations, and 1 missense
mutation. The missense mutation was not found in 100 unrelated
normal controls. The region of the protein containing the missense
mutation, p.R2065S, was identified as highly conserved in various
vertebrate species (Figure S1). In one family, the sibling of the
proband (Patient 1) identified as having a frameshift mutation of
the CHD7 gene demonstrated the same mutation, whereas no
mutation was found in their parents. Five of the 8 mutations
identified in this study were novel mutations of the CHD7 gene.
None of these novel mutations were listed in the 1000 genome
sequencing data. The CHD7 gene was not mutated in one patient
diagnosed as typical CHARGE syndrome. No chromosomal
abnormalities were identified in any of the patients.
In silico splice site prediction and in vitro splicing assay
The two intronic variations of the CHD7 gene located adjacent
to the splice site were analyzed further by in silico splice site
prediction programs and in vitro splicing assay to assess whether
these variants alter the splicing of pre-mRNA. Three different
splice site prediction programs were tested and the results are
shown in Table S3. One variation (c.5210+5G.C) was predicted
as a loss of strength of native splice donor site in all three
prediction programs. The other variation (c.5405-7G.A) resulted
in appearance of a new cryptic splice site in two of the prediction
programs.
Further study with in vitro splicing assay using pSPL3 mini-gene
system demonstrated alternative splicing more clearly and
supported the prediction results. The variation c.5210+5G.C
caused exon skipping as a result of splice donor site deterioration
and c.5405-7G.A introduced a 5-bp intronic sequence by
activation of a cryptic acceptor site (Figures S2, S3).
Clinical diagnosis of CHARGE syndrome
The diagnostic criteria proposed by Verloes [5] were applied for
the diagnosis of CHARGE syndrome (Table 3). Of nine patients,
four patients were diagnosed as typical CHARGE syndrome,
while five were categorized as atypical CHARGE syndrome.
Because of the inclusion criteria of this study, one major
(semicircular canal aplasia) and one minor criteria (rhomence-
Table 1. Diagnostic criteria by Verloes.
Criteria Definition
Major
1. Coloboma (iris or choroid, with or without microphthalmia)
2. Atresia of choanae
3. Hypoplastic semicircular canals
Minor
1. Rhombencephalic dysfunction (brainstem dysfunctions, cranial nerve VII to XII palsies and neurosensory deafness)
2. Hypothalamo-hypophyseal dysfunction (including GH and gonadotrophin deficiencies)
3. Abnormal middle or external ear
4. Malformation of mediastinal organs (heart, esophagus)
5. Mental retardation
Typical CHARGE
3 major signs
2/3 major + 2/5 minor
Partial/incomplete CHARGE
2/3 major + 1/5 minor
Atypical CHARGE
2/3 major + 0/5 minor
1/3 major + 3/5 minor
doi:10.1371/journal.pone.0024511.t001
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patients. Coloboma was identified in three patients at sites
including optic disc (Patients 6 and 8) and chorioretina (Patient
7). One of the patients with coloboma (Patient 7) was blind
whereas the other two patients demonstrated preserved vision.
Malformations of the mediastinal organs were found in 6 of 9
patients. Five had cardiac anomalies; two patients showed patent
ductus arteriosis and 3 patients demonstrated subaortic septal
hypertrophy with tricuspid and mitral regurgitation, endocardiac
cushion defect, and ventricular septal defect, respectively. Foregut
duplication requiring surgical resection was identified in one
patient (Patient 1). External ear defects including the characteristic
cup-shaped deformity of the auricles were shown in three patients,
two of whom also exhibited middle ear defects such as oval
window atresia and ossicular deformities. Unilateral incomplete
facial palsy, one of rhomencephalic dysfunctions, was shown in
three patients.
According to the criteria proposed by Verloes [5], hypothala-
mohypophyseal dysfunction which corresponds to the previous
‘‘R’’ or ‘‘G’’ of CHARGE acronym can be diagnosed only when
growth hormone or gonadotrophin deficiencies are demonstrated.
Since not all of the patients in this study performed endocrino-
logical laboratory tests, hypothalamohypophyseal dysfunction was
considered to be present when definite retardation of development
was demonstrated on objective developmental tests. However,
genital abnormalities were not included as hypothalamohypophy-
seal dysfunction in this study to eliminate the male preference in
the diagnosis of CHARGE syndrome.
In the familial case (Patient 1), the proband was diagnosed as
typical CHARGE syndrome demonstrating features such as
choanal atresia, laryngomalacia, foregut duplication, and myas-
thenia gravis in addition to the sensorineural hearing loss and
inner ear malformations. The parents who did not carry any
detectable mutations of the CHD7 gene showed normal hearing on
pure tone audiometry (data not shown) without any clinical
features of CHARGE syndrome, and the other family members
also did not have any subjective hearing loss although they were
not audiologically tested (Fig. 1A). The sibling who carried the
same frameshift mutation as the proband revealed unilateral
profound sensorineural hearing loss and normal hearing on the
contralateral side (Fig. 1B). On temporal bone CT, the sibling of
Patient 1 revealed slightly dilated but present semicircular canals
with slightly hypoplastic cochlea and normal sized internal
auditory canals on the affected side, and normal inner ear
structures on the contralateral side with normal hearing (Fig. 1C).
In contrast, Patient 1 with bilateral congenital deafness demon-
strated complete absence of all semicircular canals as well as
hypoplastic cochlea and narrow internal auditory canals bilaterally
(Fig. 1D). Atrial septal defect was present in the sibling, whereas no
cardiac defect was found in Patient 1.
Radiologic findings
Temporal bone CT of the patients revealed typical findings of
the cochlea and vestibule (Table 4). Complete aplasia of all three
semicircular canals and cochlear anomalies consistent with
cochlear hypoplasia were identified in all patients (Fig. 2A, 2B).
All but one patient exhibited narrow internal auditory canals, and
Table 2. Genetic analysis of Korean patients with CHARGE syndrome.
Patient No.
Clinical
diagnosis
Mutation
(Nucleotide)
Mutation
(Protein) Type In-vitro splicing assay In-silico assay Ref
1 Typical c.921–922delAG p.G308AfsX9 Frameshift (20)
2 Atypical c.7331T.A p.L2444X Nonsense Novel
3 Atypical c.6193C.A p.R2065S Missense Novel
4 Atypical c.6832insC p.T2278HfsX3 Frameshift Novel
5 Atypical c.5210+5G.C Splice site Exon 23 skipping Deterioration of splicing
donor site
Novel
6 Typical c.222delG p.Q74HfsX9 Frameshift Novel
7 Typical c.5405-7G.A Splice site Insertion of 5bp at cryptic
acceptor site
New cryptic splicing site (20–21)
8 Typical - - -
9 Atypical c.1465C.T p.Q489X Nonsense (20)
doi:10.1371/journal.pone.0024511.t002
Table 3. Clinical diagnosis of CHARGE syndrome.
Criteria Patient No.
1 23456 78 9
Major
Coloboma ++ +
Choanal atresia +
Semicircular canal aplasia + +++++ ++ +
Minor
Rhomencephalic dysfunction + +++++ ++ +
Hypothalamohypophyseal
dysfunction
+ ++++ ++ +
Abnormal middle/external ear + +++ +
Malformation of mediastinal
organs
+ + +++ +
Mental retardation ++ + + + +
Others
Urogenital anomalies ++
Cleft palate/lip +
Limb abnormalities +
Facial dysmorphia +
CHARGE syndrome (Verloes) Typ Atyp Atyp Atyp Atyp Typ Typ Typ Atyp
doi:10.1371/journal.pone.0024511.t003
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patients (Fig. 2B). Deformities of the incus and stapes were
identified in 6 patients, and most of these patients had combined
oval window atresia (Fig. 2B, 2D). Complete bony obliteration of
the round window was shown in only one patient (Fig. 2C).
On parasagittal view of temporal MRI, the cochleovestibular
nerve (CVN) was identified at the cerebellopontineangle and within
the internal auditory canal in 5 of 7 patients whose images were
available for review (Table 4). Because of narrow internal auditory
canals, individual branching of the CVN into the cochlear nerve
and superior/inferior vestibular nerves that is usually identified on
parasagittal imagesofMRIcould notbe distinguished inmost ofthe
patients. When the size of the CVN was compared to that of the
facial nerve on MRI, the diameter of the CVN was equal to or
larger than the facial nerve in 2 cases and smaller in 3 cases (Fig. 3).
Audiologic data and outcome of auditory rehabilitation
All of the patients demonstrated profound sensorineural hearing
loss showing no response on auditory brainstem response test.
Auditory performances evaluated at the time of initial visit were
CAP 0 in all patients except for one who showed response to
speech sounds (CAP 2) using hearing aids (Table 5).
CI was performed in 8 of 9 patients (Table 5). After at least 12
months of follow-up, 5 of 8 patients including one typical and four
atypical CHARGE patients demonstrated significant improve-
ment in auditory performances ranging from CAP 4 to 6 (Fig. 4).
Among these patients showing good outcome, one patient aged 20
years (Patient 2) who exhibited residual hearing of CAP 2
preoperatively, improved to CAP 5 after 16 months following CI.
Another patient with typical CHARGE syndrome (Patient 1)
showed good outcome of CAP 6 after 2 years following CI, and
the bisyllabic word identification improved from 0% to 70%
without visual cues. One patient (Patient 6) showed suboptimal
results after CI only reaching CAP 2 after 18 months postoperative
to CI. In two patients, no sound detection could be achieved
despite continued rehabilitation for more than 2 years following
CI. Consequently, auditory brainstem implantation was per-
formed in these two patients, following which improvements in
auditory perception were perceived (Fig. 4).
No single factor seemed to be correlated with the outcome of
auditory rehabilitation after CI in the patients. Although 3 of 4
patients diagnosed with typical CHARGE syndrome demonstrat-
ed poor outcome following CI (Patients 6, 7, and 8), Patient 1 was
the best performer of all patients included in this study.
Figure 1. Pedigree and clinical findings of familial case of CHARGE syndrome (Patient 1). (A) Pedigree shows that only two siblings are
affected by deafness either bilaterally (Patient 1; proband marked by black arrow) or unilaterally (sister of Patient 1 marked by asterisk). (B) The sister
of Patient 1 demonstrated unilateral deafness on pure tone audiometry. (C) Temporal bone CT of the sister of Patient 1 with unilateral deafness
showed slightly dilated but present semicircular canals (white arrowhead) with mild cochlear abnormality and normal sized internal auditory canal on
the affected side. (D) Temporal bone CT of Patient 1 with bilateral congenital deafness demonstrated complete absence of all semicircular canals
(black arrow).
doi:10.1371/journal.pone.0024511.g001
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and 8) all demonstrated coloboma, which may be related to poor
prognosis after CI in CHARGE syndrome. The type of mutations
of CHD7 was not correlated with outcome. On radiologic
evaluation, obliteration of BCNC was not a factor relevant to
outcome, while MRI findings demonstrating no visible CVN or
very thin CVN compared to the facial nerve at the cerebello-
pontine angle were more suggestive of poorer outcome. In
Figure 2. Computed tomography findings of inner ear anomalies typically seen in patients with CHARGE syndrome. (A) Cochlear
hypoplasia is shown by a black arrow (Patient 1). (B) Bony cochlear nerve canal is obliterated (black arrowhead) and complete aplasia of the
semicircular canals is seen (white arrowhead). The incus is dysmorphic and slightly rotated state (asterisk). Ankylosis between the incus and malleus
(white arrow) and between the ossicles and epitympanic bone (black arrows) is shown (Patient 4). (C) Bony obliteration of the round window is seen
(small white arrow) (Patient 6). (D) Oval window atresia is seen on the coronal image (large white arrow) (Patient 2).
doi:10.1371/journal.pone.0024511.g002
Table 4. Radiologic findings of patients with CHARGE syndrome.
Patient No.
Age*
(Y;M) Sex Cochlea Vestibule Middle ear Facial canal IAC BCNC
Nerve component on
MRI
1 3 F Cochlear
hypoplasia
SCC aplasia ME opacification, incus/
stapes deformity
- Narrow Patent CVN.FN
2 20;8 M Cochlear
hypoplasia
SCC aplasia OW atresia, incus/stapes
deformity
LS, TS Narrow Obliterated CVN=FN
3 4;7 M Cochlear
hypoplasia
SCC aplasia - LS Narrow Patent FN.CVN
4 2;5 M Cochlear
hypoplasia
SCC aplasia ME opacification, incus/
stapes deformity,
ankylosis, OW atresia??
- Narrow Obliterated FN.CVN
5 2;4 M Cochlear
hypoplasia
SCC aplasia - - Normal Obliterated NA
6 1;2 F Cochlear
hypoplasia
SCC aplasia OW atresia, RW atresia,
incus/stapes deformity
LS Narrow Obliterated FN only
7 2 F Cochlear
hypoplasia
SCC aplasia - LS Narrow Obliterated FN only
8 4;7 M Cochlear
hypoplasia
SCC aplasia OW atresia, incus/stapes
deformity
LS Narrow Obliterated FN.CVN
9 15** M Cochlear
hypoplasia
SCC aplasia OW atresia, incus/stapes
deformity
LS Narrow Obliterated NA
*Age at cochlear implantation;
**age at initial visit; IAC: internal auditory canal; BCNC: bony cochlear nerve canal; IP-II: incomplete partition type II; SCC: semicircular canal, ME: middle ear, CVN:
cochleovestibular nerve, FN: facial nerve; OW: oval window, RW: round window, LS: labyrinthine segment, TS: tympanic segment; NA; not available.
doi:10.1371/journal.pone.0024511.t004
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after CI both had severe combined disabilities such as blindness
(Patient 7) and severe mental retardation (Patient 8), which seems
to be associated with poor outcome after CI.
Discussion
Five novel mutations and three previously reported mutations of
the CHD7 gene was identified in Korean patients with CHARGE
syndrome presenting with profound hearing loss and typical inner
ear anomalies. None of the mutations overlapped the previously
reported mutations of the CHD7 gene found in Korean patients
[19]. The mutation rate was 89%, higher than previously reported
despite inclusion of many patients with atypical CHARGE
syndrome [8]. As Verloes [5] has emphasized, we believe that
complete aplasia of the semicircular canals is a very specific finding
that strongly suggests the presence of CHD7 mutations even if
other characteristic signs of CHARGE syndrome are missing. In
comparison to the clinical features seen in CHD7 mutation positive
cohort in previous studies, the incidence of choanal atresia (13%)
and coloboma (38%) were relatively lower in this report, which
may be a finding more specific to the Korean population [6,19].
Various types of mutations were encountered regardless of
clinical diagnosis as typical or atypical CHARGE syndrome.
Truncating mutations including nonsense and frameshift muta-
tions were most commonly detected (63%), similar to the previous
reports [8]. The patient who carried a missense mutation of the
CHD7 gene presented with the mildest symptoms demonstrating
only mild developmental delay and mental retardation without
any classical features of CHARGE syndrome other than hearing
loss and semicircular canal aplasia. Three mutations identified in
this study were previously reported; however, the phenotypes of
Figure 3. The parasagittal images of temporal MRI in patients with CHARGE syndrome. (A–B) The cochleovestibular nerve (arrowheads) is
larger in diameter than the facial nerve (arrows) at the cerebellopontine angle (A) and within the internal auditory canal (B) in Patient 1. (C–D) The
cochleovestibular nerve (arrowheads) is smaller in diameter than the facial nerve (arrows) at the cerebellopontine angle (C) and within the internal
auditory canal (D) in Patient 4.
doi:10.1371/journal.pone.0024511.g003
Table 5. Auditory rehabilitation in Patients with CHARGE syndrome.
Patient No. Age at CI (ABI)
Clinical
diagnosis
CI site
(ABI site) CI Device
Pre-op
CAP
Post-CI
CAP
Post-ABI
CAP
F/U after CI (after
ABI)
1 3 Typical R Clarion 90K 0 6 2;8
2 20;8 Atypical R MedEl Pulsar 2 5 2;3
3 4;7 Atypical R Nucleus CI24R 0 4 3
4 2;5 Atypical R Nucleus CI24R 0 4 1;1
5 2;4 Atypical R Nucleus Freedom 0 4 2;4
6 1;2 Typical R Clarion 90K 0 2 1;6
7 2 (5;10) Typical R (R) Clarion CII 0 0 1 4;7 (2)
8 4;7 (7;5) Typical L (L) Clarion 90K 0 0 2 2;9 (0;1)
9 15** Atypical - 0 - - -
doi:10.1371/journal.pone.0024511.t005
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S4) [20,21]. No mutation was found in one patient diagnosed of
typical CHARGE syndrome by direct sequencing of the 59 UTR
and coding region of the CHD7 gene. There may be small
intragenic deletions or mutations in the upstream regulatory
region of the CHD7 gene, or it is possible that a different gene
responsible for other syndromes with similar phenotypes as
CHARGE syndrome may be involved.
To date, 17 cases of molecularly confirmed familial CHARGE
syndrome have been reported, which include seven sib-pairs, three
m o n o z y g o t i ct w i np a i r s ,a n ds e v e nt w o - g e n e r a t i o nf a m i l i e s[ 6 ] .T h i s
study presents another familial case of CHARGE syndrome in which
a sib-pair carried the same frameshift mutation causing truncation of
the CHD7 gene. Since no mutation was found in their parents, de
novo mutation or germline mosaicism was suspected. The sister of the
proband had hearing loss and semicircular canal aplasia only on one
side unlike the proband who was diagnosed with typical CHARGE
syndrome and bilateral ear abnormalities, demonstrating the intra-
familial variability of CHARGE syndrome and also expanding the
phenotypic spectrum of mildly affected patients.
Radiologic analysis of patients with typical and atypical CHARGE
syndromerevealed that narrowing of the internal auditory canals and
obliteration of the BCNC were also common findings in addition to
aplasia of the semicircular canals typically seen in CHARGE
syndrome. These findings have great clinical significance because of
their correlation with CVN deficiency, which may lead to poor
outcomes after CI [15,22]. Indeed, CVN hypoplasia or aplasia was
identified in all of our patients who underwent temporal MRI. Other
than the anatomical factors, it is known that combined disabilities
such as developmental delay, mental retardation, and blindness often
seen in CHARGE syndrome act as hindering factors for proper
auditory and speech developments [13].
Most of the previous studies dealing with the auditory outcome
after CI or auditory brainstem implantation in CHARGE syndrome
rely on clinical diagnosis only and did not perform genetic analysis of
the CHD7 gene [14,16]. Since CHARGE syndrome is a clinically
complex disorder, mutational analysis of the CHD7 gene allows
molecular confirmation of the diagnosis and also enables inclusion of
mildly affected patients showing only few clinical features of
CHARGE syndrome. Following CI, a wide range of auditory
improvement was encountered from no sound perception to open-set
speech discrimination without visual cues in our patients with
CHARGE syndrome. The type of mutation of the CHD7 gene did
not demonstrate clearcorrelation with the prognosis after CI. Despite
the presence of narrow internal auditory canals and obliterated
BCNC, which may be considered as a contraindication to CI, the
outcomes of CI were promising in majority of our patients [23]. In
our opinion, CI should be recommended in CHARGE patients with
profound hearing loss even if CVN deficiency or BCNC obliteration
is present on imaging, especially when the size of the CVN is larger
than or equal to that of the facial nerve on parasagittal view of MRI
and severe mental retardation is not present.
In two patients with CHARGE syndrome who failed to perceive
any sound stimulation with a CI, auditory brainstem implantation
was performed and early results show increased attentiveness and
responsiveness despite limited improvement in auditory percep-
tion. Auditory brainstem implantation in nontumor patients has
shown promising outcomes recently, and we believe that auditory
brainstem implantation is a viable option in patients with
CHARGE syndrome in cases of failed stimulation after CI
[24,25]. Nevertheless, considering the difficulties in the pitch
ranking process after auditory brainstem implantation in children
that can be further complicated by the additional disabilities of
CHARGE patients, long and strenuous rehabilitation may be
warranted in these patients. Therefore, the parents must be
counseled carefully and informed about the variability of outcome
and the auditory rehabilitation process after CI or auditory
brainstem implantation in patients with CHARGE syndrome.
In conclusion, 8 mutations of the CHD7 gene including 5 novel
mutations were identified in Korean patients with CHARGE
syndrome showing semicircular canal aplasia and profound
hearing loss, which will broaden the genotypic and phenotypic
spectrum of CHARGE syndrome. Genetic analysis of the CHD7
gene should be performed in cases with semicircular canal aplasia
considering the high mutation rate even when the other typical
features of CHARGE syndrome are not present. CI should be
recommended in patients with CHARGE syndrome when the size
of the CVN is larger than or equal to that of the facial nerve on
MRI and mental retardation is not severe, since favorable
outcome is expected in these cases. Auditory brainstem implan-
tation may be considered in patients with CHARGE syndrome
who have failed to benefit from CI.
Supporting Information
Figure S1 Multiple sequence alignment of the CHD7
protein orthologs. CHD7 amino acid sequences of various
vertebrate species are aligned using the Clustal W2 program
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The region con-
taining the novel missense mutation, p.R2065S (indicated as an
asterisk), is highly conserved in vertebrates.
(TIF)
Figure S2 Exon-trapping analysis of the novel splice site
variation, c.5210+5G.C. For the c.5210+5G.C variation,
exons 22 and 23 of CHD7 were introduced into the pSPL3 vector
and analyzed by the in vitro splicing assay. For the wild type,
normal 623-bp mRNA was identified. For the mutant type, 463-
bp mRNA variant was seen together with the normal 623-bp
mRNA (A). When sequencing analysis was performed, the normal
623-bp mRNA demonstrated both exons 22 and 23 between the
pSPL3 exons (B), whereas the short 463-bp mRNA variant
identified in the mutant type contained only exon 22 (C). SM,
standard marker; WT, wild-type; MT, mutant type; N, negative.
(TIF)
Figure S3 Exon-trapping analysis of splice site varia-
tion, c.5405-7G.A. For the c.5405-7G.A variation, exon 26 of
Figure 4. The improvement of auditory performance after
cochlear implantation (CI) and auditory brainstem implantation
(ABI) in patients with typical or atypical CHARGE syndrome.
doi:10.1371/journal.pone.0024511.g004
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in vitro splicing assay. For the wild type, normal 393-bp mRNA was
identified, while the mutant type demonstrated only the 398-bp
mRNA variant (A). Sequencing analysis of the wild type mRNA
revealed exon 26 of CHD7 between the pSPL3 exons (B), but the
mutant mRNA variant sized 398-bp contained an additional 5-bp
intronic sequence upstream of exon 26 (C). SM, standard marker;
WT, wild-type; MT, mutant type; N, negative.
(TIF)
Table S1 Primers and PCR conditions used for CHD7
sequencing analysis.
(DOC)
Table S2 Splicing variants for in vitro splicing assay.
* The exon directly associated with the splice variation is presented
in bold. Exon 22 of Patient 5 is closely located to exon 23 and was
inserted into the pSPL3 vector together. Restriction enzyme
recognition sites of the primer sequences are underlined.
(DOC)
Table S3 In silico analysis through splice site predic-
tion programs. * Values in bold represent scores of the new
splice site that is introduced by the intronic variation.
(DOC)
Table S4 Comparison of the clinical features of patients
with CHARGE syndrome who have the same mutations
of the CHD7 gene. Of the three mutations identified in this
study that had previously been reported, clinical features were
provided for only two patients in the previous reports. TE:
tracheoesophageal.
(DOC)
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